ADM inks microbiome technology licensing agreement with Solarea Bio

21 October 2021 | News

To examine potential for use of microbes in new food and beverage solutions Image credit: Solarea Bio Image credit: Solarea Bio

Solarea Bio, a biotech company based in the US, has signed a technology licensing agreement with global nutrition leader ADM.

Solarea Bio has developed innovative technologies to harness the power of microorganisms to modulate inflammatory processes in conditions such as osteoporosis in humans, leveraging the company's extensive capabilities in data science and microbial product development experience.

This new agreement allows ADM to examine the functionality and potential for use of these microbes in new food and beverage solutions designed to support health and wellness.

"ADM is a well-established and respected partner, and this new agreement will help validate our microbial discovery platform and provide an additional path for Solarea technology to enter the market," said Dr Gerardo V Toledo, CEO and co-founder of Solarea Bio.

"The microbiome is one of ADM's six strategic platforms that are powering ADM's growth, and we're continuing to expand our capabilities and develop the next wave of innovation for consumers who are looking for foods and beverages to support their health and wellness," said Daniel Ramon Vidal, ADM Distinguished Research Fellow in the microbiome field. 


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

© Copyright 2021. Nuffoods Spectrum. All Rights Reserved.
Website Design & Developed By : SCI Knowledge Interlinks